Tesamorelin
$44.99In Stock
Tesamorelin is a stabilized 44-amino-acid GHRH analog studied across growth-hormone-axis, pituitary-function, and metabolic research as a reference GHRH compound.
In stock
Sun, Aug 16 – Thu, Aug 20
≥ 99% purity
scannable per batch
Volume Pricing
Research Overview
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH), stabilized for greater resistance to enzymatic degradation. It is a well-characterized compound in growth-hormone-axis research.
Preclinical and clinical research has examined tesamorelin across endogenous growth-hormone release, IGF-1 signaling, and visceral-adipose-tissue endpoints, making it a notable reference compound in metabolic and endocrine-research models.
Research Focus
Mechanism (Research Context)
Tesamorelin is studied for its agonism at the GHRH receptor on the pituitary, where it is observed to stimulate pulsatile growth-hormone secretion and downstream IGF-1 signaling in research models.
Intended Use
This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.
Legal Disclaimer
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.
Terms of Sale
All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.
For Research Use Only · Not for Human Consumption
Be the first to review “Tesamorelin”
Related products
Research Peptides
Semax is a short ACTH-derived peptide studied across cognitive, neuroprotective, and BDNF-pathway research as a reference nootropic peptide.
Research Peptides
TB-500 is a synthetic fragment of Thymosin Beta-4, widely studied as a reference peptide in actin-regulation, tissue-repair, and recovery research models.
Research Peptides
NAD+ is an essential redox coenzyme central to cellular energy metabolism, studied extensively across mitochondrial-function, DNA-repair, and longevity research.
Research Peptides
Tirzepatide is a dual GIP and GLP-1 receptor agonist — a leading next-generation reference compound in metabolic, glycemic, and body-composition research.
Research Peptides
BPC-157 is a synthetic pentadecapeptide derived from a protective protein sequence found in gastric juice — one of the most widely referenced compounds in tissue-repair and cytoprotection research.
Research Peptides
Retatrutide (LY3437943) is a first-in-class triple receptor agonist targeting the GIP, GLP-1, and glucagon pathways — one of the most actively studied next-generation reference compounds in metabolic research.
Research Peptides
Semaglutide is a long-acting GLP-1 receptor agonist and one of the most extensively characterized reference compounds in metabolic and appetite-signaling research.
Research Peptides
MOTS-c is a mitochondrial-derived peptide studied as a key reference compound in metabolic regulation, insulin-signaling, and cellular-stress research.
Reviews
There are no reviews yet.